Swiss National Bank - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,227,484
-49.6%
22,100
-20.2%
0.00%
-25.0%
Q2 2023$6,398,700
+2.0%
27,700
+6.9%
0.00%0.0%
Q1 2023$6,274,534
-25.2%
25,900
-10.4%
0.00%
-33.3%
Q4 2022$8,388,225
+357.6%
28,900
+2.5%
0.01%
+500.0%
Q3 2022$1,833,000
-9.2%
28,2000.0%0.00%0.0%
Q2 2022$2,019,000
-15.3%
28,200
+16.0%
0.00%0.0%
Q1 2022$2,384,000
+27.9%
24,300
+10.5%
0.00%0.0%
Q4 2021$1,864,000
+6.2%
22,0000.0%0.00%0.0%
Q3 2021$1,755,000
-15.0%
22,000
+3.8%
0.00%0.0%
Q2 2021$2,065,000
-23.2%
21,200
-7.8%
0.00%
-50.0%
Q1 2021$2,690,000
+6.6%
23,000
+1.3%
0.00%0.0%
Q4 2020$2,524,000
-6.3%
22,7000.0%0.00%0.0%
Q3 2020$2,695,000
+6.2%
22,700
+1.3%
0.00%0.0%
Q2 2020$2,537,000
+130.2%
22,400
+35.8%
0.00%
+100.0%
Q1 2020$1,102,000
-25.3%
16,500
+1.9%
0.00%
-50.0%
Q4 2019$1,476,000
+7.7%
16,200
+1.9%
0.00%
+100.0%
Q3 2019$1,371,000
-16.7%
15,900
+1.3%
0.00%
-50.0%
Q2 2019$1,646,000
-6.2%
15,700
+12.1%
0.00%0.0%
Q1 2019$1,754,000
+14.4%
14,000
+2.9%
0.00%0.0%
Q4 2018$1,533,000
-42.7%
13,600
+8.8%
0.00%
-33.3%
Q3 2018$2,677,000
-23.4%
12,5000.0%0.00%
-25.0%
Q2 2018$3,496,000
+147.4%
12,500
+3.3%
0.00%
+100.0%
Q1 2018$1,413,000
+29.4%
12,100
+1.7%
0.00%
+100.0%
Q4 2017$1,092,00011,9000.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
HealthCor Management, L.P. 1,402,250$93,614,0004.00%
Parkman Healthcare Partners LLC 30,000$2,003,0000.93%
ARMISTICE CAPITAL, LLC 216,000$14,420,0000.89%
Avoro Capital Advisors LLC 349,000$23,299,0000.79%
Rock Springs Capital Management LP 250,000$16,690,0000.69%
Capital Impact Advisors, LLC 24,351$1,626,0000.68%
Baker Brothers Advisors 1,499,212$100,087,0000.62%
EWG Elevate Inc. 11,086$740,0000.56%
SHIKIAR ASSET MANAGEMENT INC 12,000$801,0000.54%
DAFNA Capital Management LLC 13,600$908,0000.38%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders